Avecho Biotechnology Ltd has released a press release.
TGA meeting for CBD soft-gel targeting insomnia
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Avecho completes pharmaceutical CBD soft-gel product
- March 2021 Quarterly Activities Report & Appendix 4C
- Avecho receives ethics approval for CBD human trial
- AVE receives firm commitment to raise $5.06 via placement
- December 2020 Quarterly Activities Report & Appendix 4C
Later from Avecho Biotechnology
- AB Vista to explore new TPM applications for Animal Health
- Chairs Address and CEO Presentation
- Avecho to Present New CBD Data at GCI Virtual Summit
- June 2021 Quarterly Activities Report & Appendix 4C
- Phase I clinical trial testing CBD product-enrolment begins
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology